p44/42ERK1/2 MAPK and PLD activation by PGD2 preserves papillary phosphatidylcholine homeostasis

Biochemical and Biophysical Research Communications

Volumn 320, Issue 4, 2004, Pages 1055-1062

  Fernández Tome, María ^a   Favale, Nicolás ^a   Kraemer, Leticia ^a   Márquez, María Gabriela ^a   Speziale, Emir ^a   Sterin Speziale, Norma ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

MAPK; Membrane homeostasis; p44 42ERK1 2; Phosphatidylcholine synthesis; PKC; PLD; Prostaglandin D2; Renal papilla

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; ALCOHOL; CHELERYTHRINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NEOMYCIN; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE D; PHOSPHOLIPASE INHIBITOR; PROSTAGLANDIN D2; PROTEIN KINASE C INHIBITOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; HOMEOSTASIS; KIDNEY PAPILLA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL MEMBRANE; CULTURE TECHNIQUES; ENZYME ACTIVATION; HOMEOSTASIS; HUMANS; KIDNEY MEDULLA; MALE; METABOLIC CLEARANCE RATE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLCHOLINES; PHOSPHOLIPASE D; PROSTAGLANDIN D2; RATS; RATS, WISTAR;

EID: 3142656570     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.05.224     Document Type: Article

References (27)

1. Lykidis A., Jackowski S. Regulation of mammalian cell membrane biosynthesis. Prog. Nucleic Acid Res. Mol. Biol. 65:2001;361-393
2. Ghosh S., Strum J.C., Bell R.M. Lipid biochemistry: functions of glycerolipids and sphingolipids in cellular signaling. FASEB J. 1:1997;45-50
3. Hevonoja T., Pentikäinen M.O., Hyvönen M.T., Kovanen P.T., Ala-Korpela M. Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL. Biochim. Biophys. Acta. 1488(3):2000;189-210
4. Martelli A.M., Capitani S., Neri L.M. The generation of lipid signaling molecules in the nucleus. Progress Lipid Res. 38:1994;273-308
5. Slack B.E., Breu J., Wurtman R.J. Production of diacylglycerol by exogenous phospholipase C stimulates CTP: phosphocholine cytidylyltransferase activity and phosphatidylcholine synthesis in human neuroblastoma cells. J. Biol. Chem. 266(36):1991;24503-24508
6. 2. Biochim. Biophys. Acta. 1042(3):1990;380-385
7. 2. Biochim. Biophys. Acta. 1439:1999;77-88
8. Baburina I., Jackowski S. Cellular responses to excess phospholipids. J. Biol. Chem. 274(14):1999;9400-9408
9. Sterin-Speziale N.B., Kahane V.L., Setton C., Fernández M.C., Speziale E.H. Compartmental study of rat renal phospholipid metabolism. Lipids. 27:1992;10-14
10. Khan K.N., Alden C.L. Kidney. Handbook of Toxicologic Pathology. second ed. 2002;255-336 Academic Press, New York
11. Funk C.D. Prostaglandins and leukotrienes: Advances in eicosanoid biology. Science. 294:2001;1871-1875
12. Fernández-Tome M.C., Sterin-Speziale N.B. Short- and long-term treatment with indometacin causes renal phospholipid alteration: a possible explanation for indomethacin nephrotoxicity. Pharmacology. 48(6):1994;341-348
13. Fernández-Tome M.C., Speziale E.H., Sterin-Speziale N.B. Endogenous prostaglandins regulate rat renal phospholipid biosynthesis. Biochim. Biophys. Acta. 1349:1997;55-66
14. Fernández-Tome M.C., Speziale E.H., Sterin-Speziale N.B. Phospholipase C inhibitors and prostaglandins differentially regulate phosphatidylcholine synthesis in rat renal papilla. Evidence of compartmental regulation of CTP:phosphocholine cytidylyltransferase and CDP-choline:1, 2-diacylglycerol cholinephosphotransferase. Biochim. Biophys. Acta 1583. 2:2002;185-194
15. 2 synthesis regulates phosphatidylcholine biosynthesis in rat renal papillary tissue. Biochem. Pharmacol. 67:2004;245-254
16. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Canadian J. Biochem. Phys. 37(37):1959;911-917
17. Kay R.R., Fraser D., Johnston I.R. A method for the rapid isolation of nuclear membranes from rat liver. Characterisation of the membrane preparation and its associated DNA polymerase. Eur. J. Biochem. 30(1):1972;145-154
18. Vance J.E., Vance D.E. Does rat liver Golgi have the capacity to synthesize phospholipids for lipoprotein secretion? J. Biol. Chem. 263:1988;5898-5909
19. Breyer R.M., Bagdssarian C.K., Myers S.A., Breyer M. Prostanoid receptors: subtypes and signaling. Annu. Rev. Pharmacol. Toxicol. 41:2001;661-690
20. Liscovitch M., Chalifa V., Pertilr P., Chen C.-S., Cantley L.C. Novel function of phosphatidylinositol 4, 5-biphosphate as a cofactor for brain membrane phospholipase D. J. Biol. Chem. 269:1994;21403-21406
21. Morris A.J., Frohman M.A., Engebrecht J. Measurement of phospholipase D activity. Anal. Biochem. 252:1997;1-9
22. Kanashiro C.A., Khalil R.A. Signal transduction by protein kinase C in mammalian cells. Clin. Exp. Pharmacol. Physiol. 25:1998;974-985
23. Rizzo M.A., Romero G. Pharmacological importance of phospholipase D and phosphatidic acid in the regulation of the mitogen-activated protein kinase cascade. Pharmacol. Therap. 94:2002;35-50
24. Cornell R.B., Northwood I.C. Regulation of CTP:phosphocholine cytidylyltransferase by amphitrophism and relocalization. TIBS. 25:2000;441-447
25. Terada Y., Tomita K., Homma M.K., Nonoguchi H., Yang T., Yamada T., Yuasa Y., Krebs E.G., Sasaki S., Marumo F. Sequential activation of Raf-1 kinase, mitogen-activated protein (MAP) kinase kinase, MAP kinase, and S6 kinase by hyperosmolality in renal cells. J. Biol. Chem. 269:1994;31296-31301
26. Zhuang S., Hiral S.-I., Ohno S. Hyperosmolality induces activation of cPKC and nPKC a requirement for ERK1/2 activation in NIH/373 cells. Am. J. Physiol. Cell Physiol. 278:2000;C102-C109
27. Setton-Avruj C.P., Fernández-Tome M.C., Negri A., Scerbo A., Arrizurieta E., Sterin-Speziale N. Is the increase in renal papillary phospholipid biosynthesis a protective mechanism against injury? Kidney Blood Pressure Res. 19(1):1996;38-45